InTrack Investment Management Inc Sells 1,385 Shares of Danaher Co. (NYSE:DHR)

InTrack Investment Management Inc trimmed its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 13.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,584 shares of the conglomerate's stock after selling 1,385 shares during the quarter. Danaher comprises 1.6% of InTrack Investment Management Inc's portfolio, making the stock its 17th biggest holding. InTrack Investment Management Inc's holdings in Danaher were worth $1,760,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter valued at $27,000. Strategic Financial Concepts LLC acquired a new stake in shares of Danaher in the fourth quarter valued at about $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter worth about $31,000. Pineridge Advisors LLC lifted its position in shares of Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the last quarter. Finally, Kentucky Trust Co bought a new stake in Danaher during the 4th quarter valued at approximately $34,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Price Performance

Shares of NYSE:DHR traded down $0.17 on Thursday, hitting $204.55. The stock had a trading volume of 1,249,917 shares, compared to its average volume of 3,485,467. The firm's 50 day moving average price is $191.79 and its 200-day moving average price is $211.67. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The company has a market capitalization of $146.39 billion, a price-to-earnings ratio of 38.74, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. On average, equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.63%. Danaher's dividend payout ratio is 24.85%.

Insider Buying and Selling at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the sale, the chairman now directly owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on the company. Barclays lifted their price target on Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 22nd. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a research note on Friday, March 14th. Wolfe Research reduced their price target on shares of Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a report on Monday, April 7th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Danaher from $240.00 to $235.00 in a report on Thursday, June 5th. Finally, Royal Bank of Canada reiterated an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $248.17.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.